Are you living with limited mobility caused by MS? If so, could you help with a research study from Sheffield Hallam University? The study will involve an online workshop (maximum 2 hours with breaks) to help design an exercise programme for people with severe to moderate MS. The workshop will be scheduled during daytime or […]
Take part in this research study Read More »
The National Institute for Health and Care Excellence (NICE) has recommended natalizumab as a treatment option for some people living with hard to control MS in England. NICE decides which medicines are available on the NHS in England, and its guidance often influences decisions across the UK. In new final draft guidance, NICE recommends natalizumab
NICE recommends natalizumab for hard-to-control MS Read More »
A long term study of women in Norway has shown that a higher intake of vitamin D from food and supplements was linked to a lower risk of developing MS. Researchers found that women with higher vitamin D intake had a 42 percent lower risk of developing MS compared with those who consumed less. The
A new study suggests that a past infection with the Epstein Barr virus may change how the immune system behaves in people with certain genetic traits, increasing the likelihood of the body mistakenly attacking its own brain tissue. Researchers say this could help explain how viral infection and genetics come together to influence the risk
Study into links between MS and Epstein Barr Virus Read More »
We have received the following request for help with research to share with you; “My name is Melika Rostamkhani, and I am a PhD researcher at Sheffield Hallam University. I am contacting you to invite you to hear about an opportunity to contribute to this MS research project. I am currently working on a research
Can you help with this research project? Read More »
The European Network for Research and Best Practice in MS Rehabilitation (RIMS) is conducting an online survey to understand the physical activity levels of people with MS. This is an international study including participants from several countries, however this particular survey is specifically for people who live in the UK. The study aims to help
Fill out this survey Read More »
A woman with MS has become the first person in the UK to receive CAR-T cell therapy in a clinical trial testing whether this personalised treatment may slow or even halt the progression of the condition. There is no cure for MS, and while there are several treatments available to help manage symptoms or slow
First UK patient with MS trialling CAR-T cell therapy Read More »
Early results from the CCMR2 trial were announced recently. They suggest a combination of two existing drugs may be able to boost myelin repair in relapsing MS. Myelin is the protective sheath around our nerves that gets damaged in MS. Our bodies have an amazing natural ability to repair myelin. But this stops working properly
MS trial results suggest drugs could boost myelin repair Read More »
A few months ago, researcher Jess Black from Royal Holloway, University of London, shared details of a research study into social networks in MS and asked for our members to take part. Several of our members did participate and the study is now complete. Jess has shared a summary of the results with us for
Social networks in MS research study results Read More »
The set of guidelines used by neurologists to diagnose MS, known as the McDonald criteria, has recently been updated to reflect the latest research and our better understanding of MS. The new revisions (finalised in 2024 and published in September 2025) widen the evidence that can be used to diagnose MS and include new guidance on
Criteria used to diagnose MS updated Read More »
